Valuation: LivaNova PLC

Market Cap 5.01B 4.52B 4.17B 3.77B 7.14B 470B 7.31B 50.01B 19.93B 252B 18.81B 18.41B 801B P/E 2026 *
27.1x
P/E 2027 * 28x
Enterprise Value 5.09B 4.58B 4.24B 3.83B 7.24B 477B 7.42B 50.76B 20.23B 256B 19.09B 18.68B 813B EV / Sales 2026 *
3.32x
EV / Sales 2027 * 3.01x
Free-Float
98.65%
Yield 2026 *
-
Yield 2027 * -
1 day-0.18%
1 week-3.41%
Current month+15.21%
1 month+19.10%
3 months+15.78%
6 months+29.80%
Current year+47.86%
1 week 88.42
Extreme 88.4212
93.24
1 month 75.13
Extreme 75.13
99.38
Current year 56.44
Extreme 56.44
99.38
1 year 52.37
Extreme 52.37
99.38
3 years 32.48
Extreme 32.48
99.38
5 years 32.48
Extreme 32.48
99.38
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2024
Director of Finance/CFO 56 31/10/2020
Investor Relations Contact - 01/08/2022
Director TitleAgeSince
Director/Board Member 69 19/10/2015
Chairman 74 09/06/2021
Director/Board Member 62 18/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
15/9/26 Free

General Counsel

6,291 0.0114%
10/9/26 Sell

Director

-3,500 0.0064%
4/9/26 Sell

Director

-2,300 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%-3.41%+72.70%+98.65% 5.02B
-1.06%-5.38%-13.94%+16.30% 191B
+0.02%-3.19%+6.51%+43.76% 124B
-1.70%-6.14%-12.35%+16.51% 123B
-2.69%-3.46%-42.12%+4.37% 96.14B
+0.34%-1.16%-4.16%+77.09% 66.54B
+0.90%+2.55%+13.49%-8.58% 57.91B
+0.85%+0.58%-1.39%+63.88% 54.89B
+1.97%+1.08%-0.73%+57.92% 49.1B
-3.88%-6.01%-3.60%-8.41% 36.19B
Average -0.54%-1.77%+1.44%+36.15% 80B
Weighted average by Cap. -0.73%-2.88%-8.45%+27.57%

Financials

2026 *2027 *
Net sales 1.53B 1.38B 1.27B 1.15B 2.18B 144B 2.23B 15.28B 6.09B 76.9B 5.75B 5.62B 245B 1.64B 1.48B 1.36B 1.23B 2.33B 154B 2.39B 16.36B 6.52B 82.33B 6.15B 6.02B 262B
Net income 188M 169M 156M 141M 267M 17.59B 274M 1.87B 746M 9.42B 704M 689M 29.97B 165M 148M 137M 124M 234M 15.43B 240M 1.64B 654M 8.26B 617M 604M 26.3B
Net Debt 75M 67.6M 62.45M 56.46M 107M 7.03B 109M 748M 298M 3.77B 281M 275M 11.99B -85M -76.61M -70.78M -63.98M -121M -7.97B -124M -848M -338M -4.27B -319M -312M -13.59B
Projected Income Statement - Annual - LivaNova PLC
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
11/11/26 USD 90.98 -0.18% 652,684
10/11/26 USD 91.14 -1.59% 754,137
09/11/26 USD 92.61 +2.91% 628,661
06/11/26 USD 89.99 -1.26% 443,996
05/11/26 USD 91.14 -3.24% 1,242,603
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - LivaNova PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
90.98USD
Average target price
105.09USD
Spread / Average Target
+15.51%
  1. Stock Market
  2. Stocks
  3. LIVN Stock